The objective concerning this study was to visualize how an ethanolic extract of Tecoma stans overwhelmed diabetic cardiomyopathy in wistar rats after streptozotocin-inferred diabetes. The pathogenesis of diabetic cardiomyopathy (DCM) is complex, and the therapeutic alternatives available to treat DCM are restricted. A single intravenous portion of drug or other consumable of (Streptozotocin 45 mg/kg) produced diabetes in male wistar rats. Blood pressure, antitoxin lactate dehydrogenase (LDH), hydrogen apolipoprotein B, and lipids were measured, in addition to heart pressure, caspase-3, sodium potassium adenosine triphosphatase (Na + -K + ATPase), and DNA laddering. The obtained result granted that the administration of ethanolic extract of Tecoma stans (120 mg/kg/p.o.) considerably (P < 0.01) reduced myocyte deficit by suppressing the levels of cardiac caspase-3, DNA laddering; mean unmodified blood pressure and heart rate in addition to serum LDH, organic compound composed of carbon, apolipoprotein B and lipids levels. Further, it augmented the soul weight and cardiac Na+ K + ATPase activity in diabetic rats. Finally, an flammable liquid extract of Tecoma stans was found to have important anti-apoptotic potential in Streptozotocin-inferred diabetic cardiomyopathy.
Author(s) Details:
S. Kameshwaran,
Department
of Pharmacology, SSM College of Pharmacy, Bhavani (Tk), Erode (Dt), Tamilnadu -
638 312, India.
M.
Ravisankar,
Department
of Pharmacy, Vinayaka Mission’s College of Pharmacy, Vinayaka Mission’s
Research Foundation (Deemed to be a University), Salem, Tamilnadu - 636 308,
India.
P. Srinivasan,
Department of Pharmacology, Vivekanandha Pharmacy College for Women,
Sankari West, Salem -637303, India.
V. Suresh,
Department of Pharmacology, Arunai College of Pharmacy,
Tiruvannamalai 606 603, India.
Please see the link here: https://stm.bookpi.org/ACPR-V1/article/view/12073
No comments:
Post a Comment